RBR-67jth2z
Recruiting
Not Applicable
Evaluation of molecular and cellular markers for Tuberculosis diagnosis and prognosis
Instituto Gonçalo Moniz (IGM) da Fundação Oswaldo Cruz (FIOCRUZ)0 sitesOctober 9, 2023
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Instituto Gonçalo Moniz (IGM) da Fundação Oswaldo Cruz (FIOCRUZ)
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Participants with respiratory symptoms; men and women aged between 18 and 65 years (including) at the moment of informed consent; respiratory symptoms as a reason for seeking assistance at the Octávio Mangabeira Specialized Hospital (HEOM). Healthy participants; men and women aged between 18 and 65 years (inclusive) at the time of informed consent; postgraduate students, technicians, and/or researchers from the Gonçalo Moniz Institute (IGM), Fiocruz\-Ba; absence of respiratory symptoms or acute illnesses in the last 14 days.
Exclusion Criteria
- •Participants with respiratory symptoms; individuals under 18 years old and over 65 years old; using systemic corticosteroids; who have had a previous diagnosis and/or treatment for pulmonary TB in the last two years; transplant recipients, undergoing cancer treatment, or having autoimmune diseases. Healthy participants; presence of respiratory symptoms or acute illnesses in the last 14 days; previous diagnosis and/or treatment for pulmonary TB in the last two years
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Evaluation study of biological markers involved in cardiovascular diseases in childhoodcardiovascular diseasesJPRN-UMIN000002281Kyoto university100
Recruiting
Not Applicable
Clinical, molecular and functional biomarkers for PROgnosis, pathomechanisms and treatment strategies of COVID-19 (PROVID) - (PROVID-CAPNETZ)Coronavirus Disease 19 (COVID-19)U07.1J12J13J14J15J16J17J18COVID-19, virus identifiedViral pneumonia, not elsewhere classifiedPneumonia due to Streptococcus pneumoniaePneumonia due to Haemophilus influenzaeBacterial pneumonia, not elsewhere classifiedPneumonia due to other infectious organisms, not elsewhere classifiedPneumonia in diseases classified elsewherePneumonia, organism unspecifiedDRKS00022871CAPNETZ STIFTUNG, Geschäftsstelle an der Medizinischen Hochschule Hannover400
Completed
Not Applicable
Clinical, molecular and functional biomarkers for PROgnosis, pathomechanisms and treatment strategies of COVID-19 (PROVID) - (PROVID-PROGRESS)U07.1J12J13J14J15J16J17J18COVID-19, virus identifiedViral pneumonia, not elsewhere classifiedPneumonia due to Streptococcus pneumoniaePneumonia due to Haemophilus influenzaeBacterial pneumonia, not elsewhere classifiedPneumonia due to other infectious organisms, not elsewhere classifiedPneumonia in diseases classified elsewherePneumonia, organism unspecifiedDRKS00023277Charité – Universitätsmedizin Berlin, Med. Klinik m. S. Infektiologie und Pneumologie, und Arbeitsbereich Pulmonale Inflammation94
Completed
Not Applicable
Evaluation and molecular analysis of circulating tumor cells using the On-chip Sort for patients with non-small cell lung canceron-small cell lung cancerJPRN-UMIN000012488Shizuoka Cancer Center30
Recruiting
Not Applicable
Evaluation of molecular markers to predict the pattern of tumor recurrence and prognosis in pancreatric ductal adenocarcinomaC25Malignant neoplasm of pancreasDRKS00006179Klinik und Poliklinik für Allgemein-, Viszeral-, Tumor- und Transplantationschirurgie600